InvestorsHub Logo
Followers 2
Posts 86
Boards Moderated 0
Alias Born 06/10/2022

Re: None

Thursday, 12/14/2023 8:16:46 AM

Thursday, December 14, 2023 8:16:46 AM

Post# of 15
Why doesn't IMAB license Givasgtomig and Ulilidimab? I estimate that the milestone payments would be at least $500M. The share would be at least $5.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMAB News